Leukeran

Product manufactured by Aspen Global Inc.

Application Nr Approved Date Route Status External Links
NDA010669 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Leukeran (Chlorambucil) Is Indicated In The Treatment Of Chronic Lymphatic (Lymphocytic) Leukemia, Malignant Lymphomas Including Lymphosarcoma, Giant Follicular Lymphoma, And Hodgkin’s Disease. It Is Not Curative In Any Of These Disorders But May Produce Clinically Useful Palliation.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Chlorambucil CHLORAMBUCIL ZINC1115

Comments